Vistagen Therapeutics (VTGN) Shares Outstanding (Diluted) (2010 - 2026)
Vistagen Therapeutics' Shares Outstanding (Diluted) was 42.98 million in fiscal Q1 2027 (quarter ended Jun 30, 2026), up 34.6% from 31.93 million a year earlier and up 12.9% from the prior quarter.
Vistagen Therapeutics (VTGN) Shares Outstanding (Diluted) (2010 - 2026) Analysis & Trends
For FY2026 (ended Mar 31, 2026), Shares Outstanding (Diluted) at Vistagen Therapeutics came in at 38.07 million, up 23.3% from FY2025.
- Shares Outstanding (Diluted) has now increased for four consecutive fiscal years, with a five-year compound annual growth rate of 84.8% (FY2021 to FY2026).
- In earlier fiscal years, Shares Outstanding (Diluted) was 30.88 million in FY2025 (+59.5%), 19.35 million in FY2024 (+178.1%), 6.96 million in FY2023 (+293.6%) and 1.77 million in FY2022 (unchanged).
- The fiscal Q1 2027 figure marks the highest quarterly Shares Outstanding (Diluted) in data going back to fiscal Q1 2011.
- Compared with a year earlier, Shares Outstanding (Diluted) has increased for ten straight quarters, with growth averaging 48.2% over the last eight quarters.
- Over the past five years, the year-over-year growth in Shares Outstanding (Diluted) ranged from 0.0% (fiscal Q2 2022) to 468.0% (fiscal Q2 2024).
- Per Business Quant data, VTGN's Shares Outstanding (Diluted) in the three fiscal quarters before Q1 2027 was 38.07 million (Q4 2026), 42.23 million (Q3 2026) and 35.75 million (Q2 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.44 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 1.96 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.56 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 544.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 255.20 Mn |
| 10 | Vistagen Therapeutics | 13.76 Mn | 13.76 Mn | - | 42.98 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 42.98 Mn |
| Mar 31, 2026 | 38.07 Mn |
| Dec 31, 2025 | 42.23 Mn |
| Sep 30, 2025 | 35.75 Mn |
| Jun 30, 2025 | 31.93 Mn |
| Mar 31, 2025 | 30.88 Mn |
| Dec 31, 2024 | 30.71 Mn |
| Sep 30, 2024 | 30.63 Mn |
| Jun 30, 2024 | 30.60 Mn |
| Mar 31, 2024 | 19.35 Mn |
| Dec 31, 2023 | 29.39 Mn |
| Sep 30, 2023 | 10.04 Mn |
| Jun 30, 2023 | 7.34 Mn |
| Mar 31, 2023 | 6.96 Mn |
| Dec 31, 2022 | 1.77 Mn |
| Sep 30, 2022 | 1.77 Mn |
| Jun 30, 2022 | 1.77 Mn |
| Mar 31, 2022 | 1.77 Mn |
| Dec 31, 2021 | 1.77 Mn |
| Sep 30, 2021 | 1.77 Mn |
Vistagen Therapeutics Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=VTGN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "VTGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=VTGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();